These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14260757)

  • 1. DO BARBITURATES INFLUENCE THE PROTHROMBIN-PROCONVERTIN LEVEL DURING ANTICOAGULANT THERAPY?
    SAMUELSSON SM; LILIENBERG G
    Scand J Clin Lab Invest; 1965; 17():73-9. PubMed ID: 14260757
    [No Abstract]   [Full Text] [Related]  

  • 2. [PRIMARY IDIOPATHIC HYPERACTIVITY OF PROTHROMBIN AND FACTOR VII].
    GAY A; ALZETTA A; MONTALE P
    Arch Maragliano Patol Clin; 1963 Dec; 19():785-91. PubMed ID: 14120627
    [No Abstract]   [Full Text] [Related]  

  • 3. Anticoagulant therapy with tromexan and marcoumar and determination of the prothrombin-proconvertin activity by a micro-method.
    IVERSEN T
    Acta Med Scand; 1956 Sep; 155(3):161-70. PubMed ID: 13361829
    [No Abstract]   [Full Text] [Related]  

  • 4. [Tromexan and marcoumar in anticoagulant therapy; micromethod for determination of prothrombin-proconvertin activity].
    IVERSEN T
    Ugeskr Laeger; 1955 Jul; 117(27):873-8. PubMed ID: 13256759
    [No Abstract]   [Full Text] [Related]  

  • 5. ADMINISTRATION AND CONTROL OF ANTICOAGULANT TREATMENT.
    POLLER L
    Manch Med Gaz; 1964; 43():8-11. PubMed ID: 14125255
    [No Abstract]   [Full Text] [Related]  

  • 6. USE OF ANTICOAGULANTS: PRO AND CON.
    OCHSNER A; QUICK AJ; PAUL O; JULIAN OC; OLWIN JH
    Postgrad Med; 1964 Jun; 35():629-37. PubMed ID: 14143307
    [No Abstract]   [Full Text] [Related]  

  • 7. TURNOVER OF PROTHROMBIN AND FACTORS VII, IX AND X IN STATES OF HYPOCOAGULABILITY.
    HELLEMANS J; DEVREKER R; VORLAT M; VERSTRAETE M
    Acta Haematol; 1963 Jul; 30():35-41. PubMed ID: 14045902
    [No Abstract]   [Full Text] [Related]  

  • 8. A COMPARISON OF WARFARIN SODIUM AND BISHYDROXYCOUMARIN IN LONG-TERM ANTICOAGULANT THERAPY.
    BROWN KW; MACMILLAN RL
    Can Med Assoc J; 1964 Dec; 91(26):1358-9. PubMed ID: 14230912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [SKIN NECROSES IN ANTICOAGULANT THERAPY].
    STACHER A
    Wien Z Inn Med; 1964 Feb; 45():47-9. PubMed ID: 14155957
    [No Abstract]   [Full Text] [Related]  

  • 10. PETECHIAE, ECCHYMOSES, AND NECROSIS OF SKIN INDUCED BY COUMARIN CONGENERS: RARE, OCCASIONALLY LETHAL COMPLICATION OF ANTICOAGULANT THERAPY.
    NALBANDIAN RM; MADER IJ; BARRETT JL; PEARCE JF; RUPP EC
    JAMA; 1965 May; 192():603-8. PubMed ID: 14284863
    [No Abstract]   [Full Text] [Related]  

  • 11. COUMARIN THERAPY. PROTHROMBIN ACTIVITY AFTER TERMINATION OF TREATMENT.
    REILLY EB; GOODMAN JR; WARNER GF
    Calif Med; 1963 Oct; 99(4):234-5. PubMed ID: 14051485
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ANTICOAGULANT THERAPY--BOON OR BANE?
    CELANDER DR; CELANDER E; MARTIN CG
    J Am Osteopath Assoc; 1964 Dec; 64():359-65. PubMed ID: 14233113
    [No Abstract]   [Full Text] [Related]  

  • 13. Apparent resistance to oral anticoagulant therapy and influence of hypnotics on some coagulation factors.
    Johansson SA
    Acta Med Scand; 1968 Oct; 184(4):297-300. PubMed ID: 4179484
    [No Abstract]   [Full Text] [Related]  

  • 14. [Effect of tromexan and dicumarol on clotting time and prothrombin index].
    KRISTENSON A
    Nord Med; 1951 Jul; 46(29):1102-4. PubMed ID: 14863696
    [No Abstract]   [Full Text] [Related]  

  • 15. The influence of ACTH on prothrombin-proconvertin values in blood during treatment with dicumarol and phenylindanedione.
    HELLEM AJ; SOLEM JH
    Acta Med Scand; 1954; 150(5):389-93. PubMed ID: 13217736
    [No Abstract]   [Full Text] [Related]  

  • 16. [COMPARISON OF THE ACTIVITY OF INHIBITORS OF PROTHROMBIN BIOSYNTHESIS IN THE TREATMENT OF INDUCED AND NATURAL HYPOPROTHROMBINEMIA].
    RYSANEK K; SPANKOVA H; SVEHLA C; MLEJNKOVA M
    Cas Lek Cesk; 1964 Oct; 103():1228-30. PubMed ID: 14230934
    [No Abstract]   [Full Text] [Related]  

  • 17. Control of dicumarol therapy by means of a micromethod for the quantitative determination of plasma prothrombin and proconvertin.
    LUND E; DYGGVE H
    Acta Med Scand; 1954; 150(4):271-5. PubMed ID: 13217722
    [No Abstract]   [Full Text] [Related]  

  • 18. Control of anticoagulant therapy. A comparison of the thrombotest, the prothrombin-proconvertin method, and the prothrombin time.
    FICHERA C
    Acta Med Scand; 1962 Sep; 172():363-7. PubMed ID: 13945019
    [No Abstract]   [Full Text] [Related]  

  • 19. [Control of anticoagulant therapy by derivatives of coumarine (dicumarol and tromexan)].
    PUNDEL JP
    Sem Med; 1952 Mar; 28(10):199-203. PubMed ID: 14942529
    [No Abstract]   [Full Text] [Related]  

  • 20. CONTROLLED STUDY OF THE EFFECTIVE LEVEL OF LONG-TERM ANTICOAGULATION.
    MOSCHOS CB; WONG PC; SISE HS
    JAMA; 1964 Nov; 190():799-805. PubMed ID: 14202822
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.